NEED
As there is no biomarker for Parkinson’s disease, diagnosis takes a long time and can be inaccurate. This delays patient treatment and reduces clinical trial success.
APPROACH
PARKS enables quick, and accurate diagnosis of Parkinson’s based on measuring the levels of specific protein signatures in blood.
BENEFIT
Our biomarker test will facilitate faster and more accurate diagnosis and disease follow up, leading to improved treatment for patients.